Newsletter Archive

1. 11.03.26 -- Inside NIH's Strategy For Standardizing Organoid Models 11/3/2026
   11/03/26 Drug Discovery Online Newsletter
2. 10.29.26 -- Could These Target Discovery Solutions Transform Your Research? 10/29/2026
   10/29/26 Drug Discovery Online Newsletter
3. 10.23.26 -- Targeting p27 To 'Let Biology Do The Work' With Stacy Blain, CEO, Concarlo Therapeutics 10/23/2026
   10/23/26 Drug Discovery Online Newsletter
4. 10.22.26 -- How Cellular Model Solutions Are Transforming Drug Development 10/22/2026
   10/22/26 Drug Discovery Online Newsletter
5. 10.20.26 -- Reduce risk. Move Annex 1 forward. 10/20/2026
   10/20/26 Bioprocess Online Newsletter
6. 10.20.26 -- Spray Drying Advances Are Expanding Options For Poorly Soluble Molecules 10/20/2026

   10/20/26 Drug Discovery Online Newsletter

7. 10.20.26 -- Targeting p27 To 'Let Biology Do The Work' With Stacy Blain, CEO, Concarlo Therapeutics 10/20/2026
   10/20/26 Drug Discovery Online Newsletter
8. 10.15.26 -- New Advances In Drug Safety With Human-Relevant Preclinical Models 10/15/2026

   10/15/26 Drug Discovery Online Newsletter

9. 10.15.26 -- Research Partners And Solutions For Drug Discovery's Toughest Challenges 10/15/2026
   10/15/26 Drug Discovery Online Newsletter
10. 10.13.26 -- Bravo, FDA For Retiring 'Animal Testing' In Favor Of 'Nonclinical' 10/13/2026

    10/13/26 Drug Discovery Online Newsletter